165 related articles for article (PubMed ID: 32283496)
21. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
[TBL] [Abstract][Full Text] [Related]
22. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
23. International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck.
Amit M; Binenbaum Y; Trejo-Leider L; Sharma K; Ramer N; Ramer I; Agbetoba A; Miles B; Yang X; Lei D; Bjørndal K; Godballe C; Mücke T; Wolff KD; Eckardt AM; Copelli C; Sesenna E; Palmer F; Ganly I; Patel S; Gil Z
Head Neck; 2015 Jul; 37(7):1038-45. PubMed ID: 24710845
[TBL] [Abstract][Full Text] [Related]
24. A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.
Hanna GJ; ONeill A; Cutler JM; Flynn M; Vijaykumar T; Clark JR; Wirth LJ; Lorch JH; Park JC; Mito JK; Lohr JG; Kaufman J; Burr NS; Zon LI; Haddad RI
Oral Oncol; 2021 Aug; 119():105366. PubMed ID: 34091189
[TBL] [Abstract][Full Text] [Related]
25. Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
Feeney L; Hapuarachi B; Adderley H; Rack S; Morgan D; Walker R; Rauch R; Herz E; Kaye J; Harrington K; Metcalf R
Oral Oncol; 2022 Oct; 133():106028. PubMed ID: 35952580
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma.
de Sousa LG; Neto FL; Lin J; Ferrarotto R
Curr Oncol Rep; 2022 May; 24(5):621-631. PubMed ID: 35212920
[TBL] [Abstract][Full Text] [Related]
27. Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.
van Weert S; Reinhard R; Bloemena E; Buter J; Witte BI; Vergeer MR; Leemans CR
Head Neck; 2017 Mar; 39(3):456-463. PubMed ID: 27775851
[TBL] [Abstract][Full Text] [Related]
28. Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period.
van Weert S; Bloemena E; van der Waal I; de Bree R; Rietveld DH; Kuik JD; Leemans CR
Oral Oncol; 2013 Aug; 49(8):824-9. PubMed ID: 23751614
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study.
Andreasen S; Tan Q; Agander TK; Hansen TVO; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; Heegaard S; Wessel I; Homøe P
Virchows Arch; 2018 Sep; 473(3):329-340. PubMed ID: 30069755
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathologic features and prognosis of adenoid cystic carcinoma of external auditory meatus].
Gou XN; Li J; Wang XC; Liu Y; Qiu XM; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):691-695. PubMed ID: 30220123
[No Abstract] [Full Text] [Related]
31. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck.
Shen C; Xu T; Huang C; Hu C; He S
Oral Oncol; 2012 May; 48(5):445-9. PubMed ID: 22209446
[TBL] [Abstract][Full Text] [Related]
33. The role of elective neck dissection in patients with adenoid cystic carcinoma of the head and neck.
Xiao R; Sethi RKV; Feng AL; Fontanarosa JB; Deschler DG
Laryngoscope; 2019 Sep; 129(9):2094-2104. PubMed ID: 30667061
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment quantitative
Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
[TBL] [Abstract][Full Text] [Related]
35. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.
Liu Z; Fang Z; Dai T; Zhang C; Sun J; He Y
J Craniomaxillofac Surg; 2015 Jul; 43(6):751-7. PubMed ID: 25958766
[TBL] [Abstract][Full Text] [Related]
36. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
37. The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.
Kawakita D; Murase T; Ueda K; Kano S; Tada Y; Tsukahara K; Okami K; Onitsuka T; Fujimoto Y; Matoba T; Sakurai K; Nagao T; Hanai N; Kawata R; Hato N; Nibu KI; Urano M; Taguchi KI; Nakaguro M; Kusafuka K; Yamamoto H; Nagao T; Inagaki H
Int J Clin Oncol; 2020 Oct; 25(10):1774-1785. PubMed ID: 32613404
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers.
Persson M; Andersson MK; Sahlin PE; Mitani Y; Brandwein-Weber MS; Frierson HF; Moskaluk C; Fonseca I; Ferrarotto R; Boecker W; Loening T; El-Naggar AK; Stenman G
J Pathol; 2023 Nov; 261(3):256-268. PubMed ID: 37565350
[TBL] [Abstract][Full Text] [Related]
40. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.
Meyers M; Granger B; Herman P; Janot F; Garrel R; Fakhry N; Poissonnet G; Baujat B;
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Feb; 133(1):13-7. PubMed ID: 26493113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
